Global Prostate Cancer Drugs and Companies Pipeline Review H2 2017

PUNE, INDIA, February 17, 2017 /EINPresswire.com/ -- Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Prostate Cancer Diagnostic Tests pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by team of industry experts.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/789412-prostate-cancer-diagnostic-tests-medical-devices-pipeline-assessment-2016

Scope
- Extensive coverage of the Prostate Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Prostate Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Prostate Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Content: Key Points
1 Table of Contents 2
1.1 List of Tables 12
1.2 List of Figures 26
2 Introduction 27
2.1 Prostate Cancer Diagnostic Tests Overview 27
3 Products under Development 28
3.1 Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of Development 28
3.2 Prostate Cancer Diagnostic Tests - Pipeline Products by Territory 29
3.3 Prostate Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 30
3.4 Prostate Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 31
3.5 Prostate Cancer Diagnostic Tests - Ongoing Clinical Trials 32
4 Prostate Cancer Diagnostic Tests - Pipeline Products under Development by Companies 33
4.1 Prostate Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development 33
4.2 Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of Development 40
5 Prostate Cancer Diagnostic Tests Companies and Product Overview 47
5.1 3D Biomatrix, LLC Company Overview 47
5.2 3D Signatures Inc Company Overview 48
5.3 A&G Pharmaceutical Inc Company Overview 49
6 Prostate Cancer Diagnostic Tests - Recent Developments 284
6.1 Nov 22, 2016: OGT announces commercial and financial highlights for FY 2016 284
6.2 Nov 17, 2016: AroCell: Interim report, 1 January – 30 September 2016 284
6.3 Nov 17, 2016: AroCell: Interim report January - September 2016 286
6.4 Nov 14, 2016: Vermillion appoints chief medical officer 286
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/789412-prostate-cancer-diagnostic-tests-medical-devices-pipeline-assessment-2016


Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here